0001567619-22-018617.txt : 20221019 0001567619-22-018617.hdr.sgml : 20221019 20221019165445 ACCESSION NUMBER: 0001567619-22-018617 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221017 FILED AS OF DATE: 20221019 DATE AS OF CHANGE: 20221019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Amy CENTRAL INDEX KEY: 0001887865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41008 FILM NUMBER: 221319108 MAIL ADDRESS: STREET 1: 38 OUTLOOK ROAD CITY: SWAMPSCOTT STATE: MA ZIP: 01907 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IO Biotech, Inc. CENTRAL INDEX KEY: 0001865494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870909276 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 BUSINESS PHONE: 4570702980 MAIL ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 4 1 doc1.xml FORM 4 X0306 4 2022-10-17 0 0001865494 IO Biotech, Inc. IOBT 0001887865 Sullivan Amy C/O IO BIOTECH, INC. OLE MAALOES VEH 3 COPENHAGEN G7 2200 DENMARK 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 2.55 2022-10-17 4 A 0 288152 0 A 2032-10-17 Common Stock 288152 288152 D One-fourth of these options vest on 10/15/2023, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control. /s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan 2022-10-19